Kenvue

Kenvue

Yahoo Finance • 6 days ago

NetApp Moves Up In Market Cap Rank, Passing Kenvue

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, NetApp, Inc. (Symbol: NTAP) has taken over the #280 spot from Kenvue Inc (Symbol: KVUE), according to The Online Investor. Market cap... Full story

Yahoo Finance • 8 days ago

Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Aug 6 (Reuters) - Kenvue narrowly missed Wall Street estimates for second-quarter results on Thursday as inflation, ‌tariffs and currency-related costs squeezed margins. The consumer-health ‌company, currently in the midst of a $40 billio... Full story

Yahoo Finance • 16 days ago

Kenvue Increases Quarterly Cash Dividend

SUMMIT, N.J., July 29, 2026--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to th... Full story

Yahoo Finance • 18 days ago

5 Dividend Kings Continued to Pay and Raise Dividends Through Every Market Crash Since Black Monday

Quick Read Dividend Kings are 57 companies that have raised dividends for 50 or more consecutive years, and they survived Black Monday's 22% single-day Dow crash and every major market meltdown since. Warren Buffett holds 400 million shar... Full story

Yahoo Finance • 19 days ago

Is Kenvue (KVUE) Stock A Bargain With Lawsuits Back In Focus?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Kenvue stock has delivered a decline of 11.7% over the past year, yet the current Discounted Cash... Full story

Yahoo Finance • 20 days ago

Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The FDA's approval of Tylenol with Naproxen, a new over the counter pain reliever offering up to 12 hours of relief, h... Full story

Yahoo Finance • 20 days ago

FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination

(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief. This new formulat... Full story

Yahoo Finance • 21 days ago

Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse

On Tuesday's episode of CNBC's Mad Money, Jim Cramer highlighted Kimberly-Clark Corporation (NYSE:KMB) as a defensive holding for investors looking to lock in profits from high-flying technology stocks and reallocate into lower-risk value... Full story

Yahoo Finance • 25 days ago

An Overlooked Dividend King With a 54-Year Winning Streak Worth Buying Now

A Dividend King is a company that has increased its dividend for at least 50 years in a row. There are currently only 57 that can wear this crown. One of them is Kimberly-Clark (NASDAQ: KMB), the venerable company that makes tissues, pape... Full story

Yahoo Finance • last month

4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential

Quick Read Four Dividend Kings beat the S&P 500's 9% gain in 2026 by wide margins while delivering reliable dividends backed by 50+ consecutive years of increases. Target (TGT) surged 32% in 2026 and still trades cheaply at a 3.56% yield,... Full story

Yahoo Finance • last month

Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026?

Are you seeking the safety of everyday essentials or the potential of a corporate turnaround? Church & Dwight (NYSE:CHD) and Kimberly-Clark (NASDAQ:KMB) represent two very different ways to play the household products market. Church & Dwi... Full story

Yahoo Finance • last month

Illinois Appellate Court Affirms $45 Million Mesothelioma Verdict Against Johnson & Johnson and Kenvue

Decision preserves rejection of Johnson & Johnson's effort to overturn verdict DALLAS, July 10, 2026--(BUSINESS WIRE)--Dean Omar Branham Shirley, LLP (DOBS), announced today that the Illinois Appellate Court has affirmed a $45 million jur... Full story

Yahoo Finance • last month

SpaceX Stock Is Down 26% From Its Post-IPO High. History Says a $20,000 Investment Will Be Worth This Much by Mid-2027.

Key Points Among the 15 largest U.S. IPOs in history, the average stock declined 30% from its IPO price at some point during the first year. The number of SpaceX shares available for public trading will increase greatly in the next few mo... Full story

Yahoo Finance • last month

This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026

As of market close on July 7, the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) are up 9.6% and 11.1% year to date (YTD), respectively, and hovering around all-time highs. The tech sector -- which makes up 38% of the... Full story

Yahoo Finance • last month

2 Dividend Kings to Buy and Hold Forever

Plenty of stocks pay dividends, but far fewer have raised their dividends every year. And only a tiny percentage have raised their dividends every year for more than 50 years. These stocks are known as Dividend Kings. Once stocks get into... Full story

Yahoo Finance • last month

3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Quick Read Pfizer's 7% yield and forward P/E of 8 complement Viatris's three FDA PDUFA decisions arriving before year-end 2026. Kimberly-Clark's pending acquisition of Kenvue at $3.50 cash plus shares gives holders a defined takeout floor... Full story

Yahoo Finance • last month

Meet the Dividend King Stock That's Up 20% in 2026. Here's Why It Can Continue Outperforming the S&P 500 and Nasdaq-100 in the Second Half.

Key Points Colgate-Palmolive doesn’t depend on the U.S. market to drive sales growth. The company’s margins are strong, although they have ticked down in recent years. Colgate-Palmolive is expensive for all the right reasons. 10 stocks we... Full story

Yahoo Finance • last month

hould You Buy Kenvue Inc. (KVUE)’s Shares?

Kenvue Inc. (NYSE:KVUE) is one of the 10 Best Stocks to Buy According to Billionaire Glenn Dubin's Highbridge Capital. Consumer health company Kenvue Inc. (NYSE:KVUE)'s shares are down by 8.8% over the past year and are up by 10% year-to-... Full story

Yahoo Finance • last month

Kimberly-Clark’s 80% Payout Ratio: Balance Sheet Says Retirees Shouldn’t Be Scared

Quick Read KMB's dividend looks stressed at 0.99x FCF coverage, but Q1 2026 operating cash flow surged 128% while the balance sheet deleveraged sharply from 9x to 5x debt-to-equity. KMB's $48.7B acquisition of KVUE and a mid-2026 joint ve... Full story

Yahoo Finance • 2 months ago

Where to Put $1,000 When the Market Is This Uncertain

Key Points Church & Dwight's volume-driven growth, Keurig Dr Pepper's expanding energy drink portfolio, and Kenvue's strong beauty segment show these companies are finding ways to grow beyond simply passing inflation on to customers. None... Full story